These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21969423)

  • 1. Long-term bisphosphonate usage and subtrochanteric insufficiency fractures: a cause for concern?
    Yoon RS; Hwang JS; Beebe KS
    J Bone Joint Surg Br; 2011 Oct; 93(10):1289-95. PubMed ID: 21969423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Going on a drug holiday?
    Bonnick SL
    J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
    [No Abstract]   [Full Text] [Related]  

  • 3. Subtrochanteric stress fractures in patients on oral bisphosphonate therapy: an emerging problem.
    Murphy CG; O'Flanagan S; Keogh P; Kenny P
    Acta Orthop Belg; 2011 Oct; 77(5):632-7. PubMed ID: 22187839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of atypical femur fractures and the association with bisphosphonates.
    Takemoto RC; McLaurin TM; Tejwani N; Egol KA
    Bull Hosp Jt Dis (2013); 2014; 72(1):104-9. PubMed ID: 25150333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk associated with chronic use of bisphosphonates: evidence today.
    Charopoulos I; Orme S; Giannoudis PV
    Expert Opin Drug Saf; 2011 Jan; 10(1):67-76. PubMed ID: 21121870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
    Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
    J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical femur fracture during bisphosphonate drug holiday: a case series.
    Lovy AJ; Koehler SM; Keswani A; Joseph D; Hasija R; Ghillani R
    Osteoporos Int; 2015 Jun; 26(6):1755-8. PubMed ID: 25832177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
    Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
    N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
    Wang Z; Ward MM; Chan L; Bhattacharyya T
    Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
    Soen S
    Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic bilateral intramedullary femoral nails for bisphosphonate-associated signs of impending subtrochanteric hip fracture.
    Yoon RS; Beebe KS; Benevenia J
    Orthopedics; 2010 Apr; 33(4):. PubMed ID: 20415309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
    Cole RE
    Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties.
    Hollick RJ; Reid DM
    Menopause Int; 2011 Jun; 17(2):66-72. PubMed ID: 21693503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T
    Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.
    Angthong C; Angthong W
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S214-20. PubMed ID: 22619933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
    Horning JA; Czajka J; Uhl RL
    Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic intramedullary fixation for bisphosphonate-related subtrochanteric stress fracture.
    Fowler JR; Criner K; Craig MR
    Orthopedics; 2012 Jun; 35(6):e954-7. PubMed ID: 22691674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture Risk During and After Bisphosphonate Drug Holidays: A Matter of Methods?
    Adams AL
    Med Care; 2020 May; 58(5):417-418. PubMed ID: 32149922
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atypical femoral fractures in long-term osteoporotic treatment with bisphosphonates].
    Thein R; Tenenbaum S; Chechick O; Hershkovitz O; Chechik A; Caspi I
    Harefuah; 2012 Sep; 151(9):532-6, 555. PubMed ID: 23367748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.